| Announce Date | 12/09/2025 |
| EPS Normalized Actual | $1.14 (Beat by $0.08) |
| EPS GAAP Actual | $1.14 (Beat by $0.08) |
| Revenue Actual | $1.3837B |
| Revenue Surprise | Beat by $1383.7M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Feb 2030 | 8.47 | 6.98 | 8.2746 | 8.83369 | 2 |
| Jan 2030 | 9.45 | 6.26 | 9.29266 | 9.67865 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 1.07 | 1.07 | 1.3837B | 2.92% | 1383.7M |
| FQ3 2025 (Aug 2025) | 1.89 | 1.89 | 1.59984B | 100% | 1599.84M |
| FQ2 2025 (May 2025) | 0.69 | 0.69 | 1.35141B | 100% | 1351.41M |
| FQ1 2025 (Feb 2025) | 0 | 0 | 1.67692B | 100% | 1676.92M |
| FQ4 2024 (Nov 2024) | 0.94 | 0.94 | 1.34333B | 100% | 1343.33M |
| FQ2 2019 (May 2019) | 0.11 | 0.11 | 1.07679B | 100% | 1076.79M |
| FQ3 2019 (Jul 2019) | 0.63 | 0.63 | 1.23741B | 100% | 1237.41M |
| FQ4 2019 (Oct 2019) | 0.37 | 0.37 | 1.1452B | 100% | 1145.2M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Nov 2027) | 1.4374 | -- | 1.39835 | 1.47051 | 4 |
| FQ3 2027 (Aug 2027) | 2.4873 | -- | 2.41973 | 2.5446 | 3 |
| FQ2 2027 (May 2027) | 1.0195 | -- | 0.9918 | 1.04298 | 4 |
| FQ1 2027 (Feb 2027) | 2.7285 | -- | 2.66499 | 2.84466 | 5 |
| FQ4 2026 (Oct 2026) | 1.16479 | 8.14 | 1.13256 | 1.20959 | 7 |
| FQ3 2026 (Jul 2026) | 2.50753 | 24.63 | 2.43815 | 2.60397 | 10 |
| FQ2 2026 (May 2026) | 1.7118 | 59.69 | 1.64694 | 1.81765 | 8 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Nov 2027) | 1.57B | -- | 1.54B | 1.6B | 5 |
| FQ3 2027 (Aug 2027) | 1.81B | -- | 1.77B | 1.84B | 4 |
| FQ2 2027 (May 2027) | 1.54B | -- | 1.51B | 1.56B | 8 |
| FQ1 2027 (Feb 2027) | 2.15B | -- | 2.11B | 2.22B | 6 |
| FQ4 2026 (Oct 2026) | 1.54B | 10.33 | 1.51B | 1.59B | 8 |
| FQ3 2026 (Jul 2026) | 1.76B | 9.3 | 1.73B | 1.82B | 12 |
| FQ2 2026 (May 2026) | 1.66B | 18.41 | 1.61B | 1.74B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 1.07 | 1.07 | 100% | |
| FQ3 2025 (Aug 2025) | 1.89 | 1.89 | 100% | |
| FQ2 2025 (May 2025) | 0.69 | 0.69 | 100% | |
| FQ1 2025 (Feb 2025) | 0 | 0 | NAN% | |
| FQ4 2024 (Nov 2024) | 0.94 | 0.94 | 100% | |
| FQ2 2019 (May 2019) | 0.11 | 0.11 | 100% | |
| FQ3 2019 (Jul 2019) | 0.63 | 0.63 | 100% | |
| FQ4 2019 (Oct 2019) | 0.37 | 0.37 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $1.38B | $1383.7M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $1.6B | $1599.84M | 100% |
| FQ2 2025 (May 2025) | $0B | $1.35B | $1351.41M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $1.68B | $1676.92M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $1.34B | $1343.33M | 100% |
| FQ2 2019 (May 2019) | $0B | $1.08B | $1076.79M | 100% |
| FQ3 2019 (Jul 2019) | $0B | $1.24B | $1237.41M | 100% |
| FQ4 2019 (Oct 2019) | $0B | $1.15B | $1145.2M | 100% |